NETAT: Neuroendocrine and Adrenal Tumors
Sponsor
University of Pennsylvania (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04432532
Collaborator
(none)
999
16
Study Details
Study Description
Brief Summary
This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in conjunction with IRB#831990 which is a retrospective protocol. The University of Pennsylvania will be a contributing site with the University of Michigan as the coordinating site for the A5 alliance, a multi-institutional collaborative designed to study neuroendocrine and adrenal tumors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
999 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Neuroendocrine and Adrenal Tumors: Biochemical, Histopathologic and Genetic Studies
Anticipated Study Start Date
:
Sep 1, 2022
Anticipated Primary Completion Date
:
Jan 1, 2023
Anticipated Study Completion Date
:
Jan 1, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Neuroendocrine Tumor
|
Other: No intervention
There are no interventions
|
| Adrenal Tumor
|
Other: No intervention
There are no interventions
|
Outcome Measures
Primary Outcome Measures
- Survival [10 years]
Secondary Outcome Measures
- Tumor Recurrence [10 years]
We want to record recurrences in our patient population
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- diagnosed with neuroendocrine and/or an adrenal tumor
Exclusion Criteria:
-
pregnant women
-
prisoners
-
people under the age of 18
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Pennsylvania
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Heather Wachtel, MD,
Assistant Professor of Surgery,
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04432532
Other Study ID Numbers:
- 832475
First Posted:
Jun 16, 2020
Last Update Posted:
Dec 13, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: